Adenovirus E1A protein is directly involved in oncogenic transformation by adenovirus. It is a nuclear protein with structural and functional homology to the product of the important myc human oncogene. E1A protein stimulates transcription of genes introduced into mammalian cells by transfection or viral infection. The mechanism of this process, called E1A transactivation, is not yet well understood. Results from the first funding period indicate that specific host cell transcription factors including TFIIIC1, TFIIIC2 (both identified during the first funding period), and the TATA-box transcription factor increase in activity after expression of E1A. However, none of these host cell transcription factors have yet been purified to homogeneity. Consequently, it has not been possible to directly determine the effect of E1A protein on the quantity and specific activities of these transcription factors. To do this, and to pursue the biochemical mechanisms by which the activities of these transcription factors are increase by E1A protein, we propose to purify these transcription factors to homogeneity. This will enable a direct characterization of the polypeptides which comprise these activities. Specific antisera will be raised against the purified proteins and used to determine the amounts and physical properties of the proteins in adenovirus and mock infected HeLa cells. Purified transcription factors will also be used in studies of the functions of the transcription factors in transcription factors in transcription initiation. Interactions of TFIIIC2 and TFIIIC1 with wild-type and mutant VAI, tRNA, and 5S rRNA genes will be analyzed by nuclease protection and binding interference studies. The interaction of the TATA-box factor with wild-type and mutant Ad2 E1B promoters which have been well characterized for their transcription in vivo will be analyzed. cDNAs and genes encoding the TFIIIC1, TFIIIC2 and TATA-box TF polypeptides will be isolated and analyzed. This will yield information on the amino acid sequence of the proteins which will be useful in their characterization in infected and uninfected cells. For example, it is possible that these proteins are regulated by post- translational modifications such as phosphorylation. Amino acid sequence would be crucial to defining the sites of modification. Genomic and cDNA clones will also be useful in analyzing the transcriptional regulation of these genes in response to E1A and growth factors. Results form the proposed studies should contribute to an understanding of transcription factor function and regulation and the mechanism of E1A transactivation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37CA041062-04
Application #
3482490
Study Section
Experimental Virology Study Section (EVR)
Project Start
1985-07-01
Project End
1989-05-31
Budget Start
1988-07-01
Budget End
1989-05-31
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Smale, S T; Schmidt, M C; Berk, A J et al. (1990) Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc Natl Acad Sci U S A 87:4509-13
Schmidt, M C; Kao, C C; Pei, R et al. (1989) Yeast TATA-box transcription factor gene. Proc Natl Acad Sci U S A 86:7785-9
Schmidt, M C; Zhou, Q; Berk, A J (1989) Sp1 activates transcription without enhancing DNA-binding activity of the TATA box factor. Mol Cell Biol 9:3299-307
Yoshinaga, S K; L'Etoile, N D; Berk, A J (1989) Purification and characterization of transcription factor IIIC2. J Biol Chem 264:10726-31
Dean, N; Berk, A J (1988) Ordering promoter binding of class III transcription factors TFIIIC1 and TFIIIC2. Mol Cell Biol 8:3017-25
Brunet, L J; Berk, A J (1988) Concentration dependence of transcriptional transactivation in inducible E1A-containing human cells. Mol Cell Biol 8:4799-807
Leong, K; Brunet, L; Berk, A J (1988) Factors responsible for the higher transcriptional activity of extracts of adenovirus-infected cells fractionate with the TATA box transcription factor. Mol Cell Biol 8:1765-74
Dean, N; Berk, A J (1987) Separation of TFIIIC into two functional components by sequence specific DNA affinity chromatography. Nucleic Acids Res 15:9895-907
Boulanger, P A; Yoshinaga, S K; Berk, A J (1987) DNA-binding properties and characterization of human transcription factor TFIIIC2. J Biol Chem 262:15098-105
Fradkin, L G; Yoshinaga, S K; Berk, A J et al. (1987) Inhibition of host cell RNA polymerase III-mediated transcription by poliovirus: inactivation of specific transcription factors. Mol Cell Biol 7:3880-7

Showing the most recent 10 out of 16 publications